fda warning letters glp-1 september 2025 news issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA takes aim at telehealth

In a study of men who did not respond to Viagra, 1/3 were able to achieve at least an adequate erection satisfactory for sexual intercourse after taking Bremelanotide PT 141

In the United States, while the FDA has approved over 480 therapeutic peptides and proteins for a variety of uses [14], it has not reviewed the safety and efficacy of ipamorelin

The differences in the effects of GLP-1RA on tumors may be related to differences in experimental subjects, differences in inclusion and exclusion criteria, differences in experimental methods, groups, and instruments

Here are the drugs they reviewed: Other conditions now being evaluated for GLP-1 effectiveness include: Parkinsons Disease Alzheimers dementia Alcohol use disorder These drugs are also being evaluated for obsessive-compulsive disorder, opioid use disorder, gambling, and other mental health diagnoses, although these are not mentioned in this review